Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 52,483 $ 51,032
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 8,946 6,278
Costs recognized on sale of acquired inventory 3,135 2,464
Deferred income taxes (3,006) (1,487)
Stock-based compensation expense 1,895 1,088
Excess tax benefit from stock option exercises (40) (64)
Losses by equity method investees 0 83
Other 316 212
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables 2,891 3,645
Inventories (1,243) (1,362)
Prepaid expenses 31 (193)
Trade accounts payable and accrued expenses (994) 260
Salaries, wages and related accruals 143 (390)
Income taxes payable (650) (1,016)
Net cash provided by operating activities 63,907 60,550
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition, net of cash acquired (103,149) 0
Purchase of available-for-sale investments (71,877) (42,620)
Proceeds from sales of available-for-sale investments 34,345 16,537
Proceeds from maturities of available-for-sale investments 34,193 22,322
Additions to property and equipment (7,458) (10,735)
Distribution from unconsolidated entity 85 0
Increase in other long-term assets (55) (424)
Net cash used in investing activities (113,916) (14,920)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (22,485) (21,360)
Proceeds from stock option exercises 3,560 824
Excess tax benefit from stock option exercises 40 64
Purchase of common stock for stock bonus plans 0 (573)
Net cash used in financing activities (18,885) (21,045)
Effect of exchange rate changes on cash and cash equivalents 3,510 2,026
Net increase in cash and cash equivalents (65,384) 26,611
Cash and cash equivalents at beginning of period 163,786 116,675
Cash and cash equivalents at end of period $ 98,402 $ 143,286